|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2003-11-12
|
|
pubmed:abstractText |
We recently generated transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation (RET-MEN2A). Mammary tumors with frequent lung metastasis were developed in 22% of female transgenic mice in a stochastic fashion. In the current study, we established two cell lines (named MKK-f and MKK-s) from mammary tumors developed in RET-MEN2A transgenic mice. MKK-f and MKK-s were derived from well-differentiated ductal carcinoma and sarcomatous spindle cell carcinoma, respectively. MKK-f cells show epithelial-like morphology with a doubling time of 19 h, and MKK-s cells show spindle-shaped morphology with a doubling time of 15 h. When inoculated in immunodeficient mice, both cell lines were tumorigenic, metastasized to the lung and displayed histological features similar to those of the primary tumors. They maintained a high level of RET expression and activation of signaling molecules downstream of RET. Consistent with the histological phenotype, expression of E-cadherin was almost undetectable in MKK-s cells, whereas its expression was very high in MKK-f cells. When the difference of gene expression between the two cell lines was analyzed using cDNA microarrays including approximately 900 genes/ESTs, a total of 21 up- or down-regulated (> 2.0-fold) genes were identified. Differentially regulated genes included thymosin beta-10, fibroblast growth factor receptor 4, aldo-keto reductase and caspase 6 genes, which are known to be associated with tumor development and progression. These results may reflect the profiles of the transcriptional changes associated with dedifferentiation or progression of mammary carcinomas developed in genetically engineered mice.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alcohol Oxidoreductases,
http://linkedlifedata.com/resource/pubmed/chemical/CASP6 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Cadherins,
http://linkedlifedata.com/resource/pubmed/chemical/Casp6 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 6,
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/FGFR4 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Fgfr4 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-ret,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Fibroblast Growth...,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Fibroblast Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Ret protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Thymosin,
http://linkedlifedata.com/resource/pubmed/chemical/carbonyl reductase (NADPH),
http://linkedlifedata.com/resource/pubmed/chemical/thymosin beta(10)
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1347-9032
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
94
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
992-7
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:14611677-Alcohol Oxidoreductases,
pubmed-meshheading:14611677-Animals,
pubmed-meshheading:14611677-Cadherins,
pubmed-meshheading:14611677-Carcinoma, Ductal,
pubmed-meshheading:14611677-Caspase 6,
pubmed-meshheading:14611677-Caspases,
pubmed-meshheading:14611677-Cell Differentiation,
pubmed-meshheading:14611677-Female,
pubmed-meshheading:14611677-Gene Expression Profiling,
pubmed-meshheading:14611677-Humans,
pubmed-meshheading:14611677-Lung Neoplasms,
pubmed-meshheading:14611677-Mammary Neoplasms, Experimental,
pubmed-meshheading:14611677-Mice,
pubmed-meshheading:14611677-Mice, SCID,
pubmed-meshheading:14611677-Mice, Transgenic,
pubmed-meshheading:14611677-Multiple Endocrine Neoplasia Type 2a,
pubmed-meshheading:14611677-Mutation,
pubmed-meshheading:14611677-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:14611677-Proto-Oncogene Proteins,
pubmed-meshheading:14611677-Proto-Oncogene Proteins c-ret,
pubmed-meshheading:14611677-Receptor, Fibroblast Growth Factor, Type 4,
pubmed-meshheading:14611677-Receptor Protein-Tyrosine Kinases,
pubmed-meshheading:14611677-Receptors, Fibroblast Growth Factor,
pubmed-meshheading:14611677-Sarcoma,
pubmed-meshheading:14611677-Thymosin,
pubmed-meshheading:14611677-Tumor Cells, Cultured
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Establishment and characterization of mouse mammary carcinoma cell lines expressing RET with a multiple endocrine neoplasia 2A mutation.
|
|
pubmed:affiliation |
Department of Molecular Pathology, Center for Neural Disease and Cancer, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya 466-8550.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
